Unexpected T-cell reactions to adenoviral COVID-19 vaccines discovered

FHS
July 20, 2024
1:15 am

Researchers from the University of Liverpool’s Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

The study reveals that the SARS-CoV-2 delta variant was transmitted from humans to lions at a Singapore zoo, emphasizing the risk to captive and endangered

October 30, 2023

Pharmalittle: Bluebird claims big insurer will cover its sickle cell therapy; House Republicans threaten to subpoena FDA commish

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

December 15, 2023

AbbVie wins UK NICE endorsement for subcutaneous Tepkinly in DLBCL

Share this article Tepkinly has received accelerated approval from the FDA and a conditional marketing authorisation from the European Commission as third-line therapy in adult

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.